These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21933028)

  • 1. Efficient large volume lentiviral vector production using flow electroporation.
    Witting SR; Li LH; Jasti A; Allen C; Cornetta K; Brady J; Shivakumar R; Peshwa MV
    Hum Gene Ther; 2012 Feb; 23(2):243-9. PubMed ID: 21933028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.
    Mendenhall A; Lesnik J; Mukherjee C; Antes T; Sengupta R
    J Vis Exp; 2012 Apr; (62):e3171. PubMed ID: 22508377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
    Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
    J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of lentiviral vectors for transducing cells from the central nervous system.
    Li M; Husic N; Lin Y; Snider BJ
    J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of stable suspension producer cell lines for serum-free lentivirus production.
    Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H
    Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application.
    Merten OW; Charrier S; Laroudie N; Fauchille S; Dugué C; Jenny C; Audit M; Zanta-Boussif MA; Chautard H; Radrizzani M; Vallanti G; Naldini L; Noguiez-Hellin P; Galy A
    Hum Gene Ther; 2011 Mar; 22(3):343-56. PubMed ID: 21043787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.
    Zhang XY; Kutner RH; Bialkowska A; Marino MP; Klimstra WB; Reiser J
    Retrovirology; 2010 Jan; 7():3. PubMed ID: 20100344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
    Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
    Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells.
    Do Minh A; Tran MY; Kamen AA
    Methods Mol Biol; 2020; 2086():77-83. PubMed ID: 31707669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
    Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
    Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
    Beyer WR; Westphal M; Ostertag W; von Laer D
    J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum-free medium suspension cultures.
    Vaz TA; Rodrigues AF; Coroadinha AS
    Biotechnol J; 2024 Jan; 19(1):e2300212. PubMed ID: 37903159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of lentiviral vector tropism in cerebellar Purkinje cells in vivo by a lysosomal cysteine protease cathepsin K.
    Goenawan H; Hirai H
    J Neurovirol; 2012 Dec; 18(6):521-31. PubMed ID: 23070819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses.
    Hu S; Mohan Kumar D; Sax C; Schuler C; Akkina R
    Virology; 2016 Jan; 488():162-8. PubMed ID: 26650691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles.
    Mitta B; Rimann M; Fussenegger M
    Metab Eng; 2005; 7(5-6):426-36. PubMed ID: 16102993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
    Kumar M; Bradow BP; Zimmerberg J
    Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.